- Maastricht University
- DBSL B.V.
- Amsterdam Scientific Instruments
- Da Vinci Laboratory Solutions
- University of Liège
- University of Hasselt
- Katholieke Universiteit Leuven
- University Hospital Aachen
- Dutch Screening Group B.V.
For more information click see here.
Lipids comprise a major class of biological compounds which govern essential functions in living organisms like cellular compartmentalisation, energy storage, and chemical signaling. A central challenge in lipidomics, the scientific field dedicated to profiling lipid constitution and activity in biological systems, is aimed at elucidating the full spectrum of diverse lipid species in different physiological states and across a broad range of concentrations and conformations. Unraveling the composition of the lipidome will have an immediate and lasting impact on the efficacy of disease diagnostics and evolving therapeutic technologies. Such a monumental undertaking requires the concerted efforts of an interdisciplinary network of experienced researchers and creative scientific enterprises. The EURLipids consortium funded by Interreg EMR embodies an international project platform with the purpose of establishing a renowned Lipidomics knowledge center. The consortium integrates expertise, resources, and practices across technical and geographical borders in academia and biomedical science, with the overarching objective to facilitate breakthroughs in causality between lipid profiles and disease progression. A primary focus area involves application of advanced mass spectrometry-based imaging approaches to investigate neuro-degenerative diseases (Alzheimer and Multiple Sclerosis), cancer, and cardio-renal disorders. Through ASI’s ongoing partnership in the EURLipids project, the Timepix has been embraced as a core technology for furthering lipidomics research in clinical pathology using a combination of high-throughput and high-resolution stigmatic imaging mass spectrometry techniques. ASI endeavours to valorize its contribution in this collaboration by innovating sustainable commercial technologies and analytical workflows which support the lipidomics screening framework and educational project initiatives.